Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/306% below fair value
$65.66−1.76 (-2.61%)
Close on Nov 13, 2026Market cap $210.11MP/E 18.1Yield –
Pro Dex total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Pro Dex's total debt was $12.27M at Sep 30, 2026. For fiscal 2026 it was $13.27M, up 43.5% from the year before. The highest annual figure on record is $13.27M in fiscal 2026.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $13.27M | +43.5% |
| FY2025 | Jun 30, 2025 | $9.25M | +22.7% |
| FY2024 | Jun 30, 2024 | $7.54M | -41.0% |
| FY2021 | Jun 30, 2021 | $12.77M | +224.6% |
| FY2020 | Jun 30, 2020 | $3.93M | -13.7% |
| FY2019 | Jun 30, 2019 | $4.56M | +11012.2% |
| FY2018 | Jun 30, 2018 | $41.00K | -65.5% |
| FY2017 | Jun 30, 2017 | $119.00K | +158.7% |
| FY2016 | Jun 30, 2016 | $46.00K | -34.3% |
| FY2015 | Jun 30, 2015 | $70.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $12.27M | +42.2% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $13.27M | +43.5% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $14.31M | +45.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $8.01M | -23.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $8.63M | -22.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $9.25M | +22.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $9.86M | -19.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $10.47M | -13.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $11.08M | -11.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $7.54M | -41.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $12.22M | -4.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $12.16M | +37.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $12.47M | +230.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $12.77M | +224.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $12.81M | +213.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $8.85M | +108.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $3.77M | -14.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.93M | -13.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $4.09M | -13.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $4.25M | -12.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $4.40M | -12.6% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $4.56M | +11012.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $4.71M | +31320.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $4.87M | +5250.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $5.03M | +10841.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $41.00K | -65.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $15.00K | -80.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $91.00K | 0.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $46.00K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $119.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $76.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $91.00K | – |
See a number that looks wrong?